Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Viruses|November 13, 2020
HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription SitesKevin M Tuffy, Rebecca J Kaddis Maldonado, Jordan Chang, et al.The Pediatric Infectious Disease Journal|January 6, 2026
Reliability of RSV Antigen Diagnostic Tests in the Presence of NirsevimabSarah R Sincero, Kelly Ann Mahool, Emma Schaefer, et al.Journal of Virology|July 11, 2014
Influenza A and B virus intertypic reassortment through compatible viral packaging signalsSteven F Baker, Aitor Nogales, Courtney Finch, et al.Mbio|April 9, 2020
Visualizing Association of the Retroviral Gag Protein with Unspliced Viral RNA in the NucleusRebecca J Kaddis Maldonado, Breanna Rice, Eunice C Chen, et al.Frontiers in Immunology|October 30, 2023
Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protectionTyler Brady, Corinne Cayatte, Tiffany L Roe, et al.Clinical & Translational Immunology|May 2, 2022
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccinationDeidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, et al.Clinical & Translational Immunology|June 14, 2024
Serum AZD7442 (tixagevimab-cilgavimab) concentrations and <i>in vitro</i>IC<sub>50</sub> values predict SARS-CoV-2 neutralising antibody titresLindsay E Clegg, Oleg Stepanov, Sam Matthews, et al.Vaccine|September 6, 2024
Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY)Kevin M Tuffy, Bahar Ahani, Joseph B Domachowske, et al.Microbiology Spectrum|March 6, 2023
Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron SubvariantsTiffany L Roe, Tyler Brady, Nicolette Schuko, et al.Microbiology Spectrum|August 22, 2022
Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance MonitoringTyler Brady, Tianhui Zhang, Kevin M Tuffy, et al.Pageof 2